AMGN vs GILD
Amgen (AMGN) and Gilead Sciences (GILD) compared side by side. Amgen (AMGN) is larger, with a market cap of $237.5B versus $193.5B for Gilead Sciences, about 1.2 times the size. AMGN returned +54.1% over the past year including dividends, versus +32.4% for GILD, through October 23, 2026..
Head to head
| Metric | AMGN | GILD |
|---|---|---|
| Market cap | $237.5B | $193.5B |
| P/E (TTM) | 27.3x | — |
| Forward P/E | 17.9x | 15.6x |
| Revenue (TTM) | $38.1B | $30.5B |
| Revenue growth | 9.5% | 10.2% |
| Gross margin | 71.9% | 79.6% |
| Operating margin | 35.5% | 33.7% |
| Free cash flow | $10.2B | $12.9B |
| Dividend yield | 2.29% | 2.10% |
| 1-year return | +54.1% | +32.4% |
| 5-year return (annual) | +19.7% | +22.6% |
| Max drawdown | -78% | -71% |
| FI Handbook grade | B- | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$10.0K
$15.0K
$20.0K
20222023202420252026
AMGN vs GILD FAQ
Which is bigger, AMGN or GILD?
Amgen (AMGN) is larger, with a market cap of $237.5B versus $193.5B for Gilead Sciences, about 1.2 times the size.
Which stock performed better over the past year, AMGN or GILD?
AMGN returned +54.1% over the past year including dividends, versus +32.4% for GILD, through October 23, 2026.
Which pays a higher dividend, AMGN or GILD?
AMGN yields 2.29% versus 2.10% for GILD.
Full pages: Amgen · Gilead Sciences